药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Orciprenaline
Etorphine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Etorphine.
Orciprenaline
Ethylmorphine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Ethylmorphine.
Orciprenaline
Diamorphine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Diamorphine.
Orciprenaline
Dihydroetorphine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Dihydroetorphine.
Orciprenaline
Methadyl acetate
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Methadyl acetate.
Orciprenaline
Dezocine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Dezocine.
Orciprenaline
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Tubocurarine.
Orciprenaline
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Tubocurarine.
Orciprenaline
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tubocurarine.
Orciprenaline
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Tubocurarine.
Orciprenaline
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Tubocurarine.
Orciprenaline
Levacetylmethadol
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Levacetylmethadol.
Orciprenaline
Alaproclate
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Alaproclate.
Orciprenaline
Ritanserin
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Ritanserin.
Orciprenaline
Indalpine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Indalpine.
Orciprenaline
Levomilnacipran
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Levomilnacipran.
Orciprenaline
Seproxetine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Seproxetine.
Orciprenaline
Desvenlafaxine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Desvenlafaxine.
Orciprenaline
Milnacipran
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Milnacipran.
Orciprenaline
Dapoxetine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Dapoxetine.